Lei Huang Selected Research

mouse propeptide convertase 5

8/2017	Beneficial effects of Huaiqihuang on hyperglycemia-induced MPC5 podocyte dysfunction through the suppression of mitochondrial dysfunction and endoplasmic reticulum stress.
8/2016	Huaiqihuang may protect from proteinuria by resisting MPC5 podocyte damage via targeting p-ERK/CHOP pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lei Huang Research Topics

Disease

181	Neoplasms (Cancer) 08/2022 - 05/2003
53	Infections 01/2022 - 01/2002
40	Inflammation (Inflammations) 08/2022 - 03/2008
31	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2003
22	Carcinoma (Carcinomatosis) 06/2022 - 11/2003
22	Brain Injuries (Brain Injury) 01/2022 - 07/2015
22	Carcinogenesis 10/2021 - 03/2005
21	Neoplasm Metastasis (Metastasis) 11/2021 - 05/2011
19	COVID-19 01/2022 - 01/2020
16	Wounds and Injuries (Trauma) 10/2022 - 06/2004
16	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 01/2004
16	Hypoxia (Hypoxemia) 01/2021 - 01/2004
16	Heart Arrest (Cardiac Arrest) 05/2020 - 06/2004
15	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 04/2005
14	Stroke (Strokes) 05/2022 - 11/2014
14	Brain Edema (Cerebral Edema) 01/2022 - 01/2016
14	Lung Neoplasms (Lung Cancer) 01/2022 - 12/2007
13	Neuroinflammatory Diseases 09/2022 - 07/2015
13	Stomach Neoplasms (Stomach Cancer) 01/2022 - 03/2005
13	Hypertension (High Blood Pressure) 11/2020 - 04/2013
11	Fibrosis (Cirrhosis) 10/2022 - 01/2004
11	Disease Resistance 01/2017 - 07/2014
10	Adenocarcinoma 04/2022 - 01/2015
10	Ventricular Fibrillation 01/2022 - 09/2004
10	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 12/2014
10	Myocardial Infarction 01/2022 - 08/2014
10	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 10/2021 - 01/2017
10	Heart Failure 08/2021 - 11/2005
10	Bites and Stings (Sting) 01/2021 - 10/2013
9	Aneurysm (Aneurysms) 03/2022 - 01/2015
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 09/2010
9	Ischemic Stroke 01/2021 - 12/2016
9	Pancreatitis 08/2019 - 04/2008
8	Hemorrhage 01/2022 - 03/2005
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 11/2016
8	Necrosis 12/2021 - 10/2004
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2021 - 01/2012
8	Obesity 12/2020 - 07/2005
8	Virus Diseases (Viral Diseases) 11/2020 - 01/2002
7	Sepsis (Septicemia) 01/2022 - 02/2006
7	Autoimmune Diseases (Autoimmune Disease) 12/2021 - 04/2010
7	Pain (Aches) 10/2020 - 06/2004
7	Insulin Resistance 10/2020 - 09/2009
7	Reperfusion Injury 01/2020 - 10/2004
7	Infarction (Infarctions) 10/2019 - 11/2014
7	Shock 10/2017 - 02/2006
6	Cerebral Hemorrhage 01/2022 - 01/2018
6	Pneumonia (Pneumonitis) 01/2022 - 08/2014
6	ST Elevation Myocardial Infarction 01/2022 - 08/2014
6	Disease Progression 01/2022 - 10/2014
6	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 01/2015

Drug/Important Bio-Agent (IBA)

59	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2004
37	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2005
30	MicroRNAs (MicroRNA)IBA 01/2022 - 09/2010
29	Messenger RNA (mRNA)IBA 12/2022 - 01/2004
28	Pharmaceutical PreparationsIBA 08/2022 - 09/2005
26	Biological ProductsIBA 07/2022 - 03/2005
21	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2010
21	CytokinesIBA 11/2021 - 04/2004
19	AntigensIBA 06/2022 - 01/2002
16	Interleukin-6 (Interleukin 6)IBA 01/2022 - 09/2012
14	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2015
12	Therapeutic UsesIBA 01/2022 - 12/2006
12	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 12/2012
12	InterferonsIBA 01/2021 - 10/2014
11	EnzymesIBA 01/2022 - 01/2013
11	VaccinesIBA 01/2022 - 10/2014
10	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2010
10	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2013
10	Small Interfering RNA (siRNA)IBA 01/2022 - 03/2010
10	Paclitaxel (Taxol)FDA LinkGeneric 05/2021 - 04/2005
10	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2021 - 01/2013
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 12/2006
9	Oncogene Proteins (Oncogene Protein)IBA 11/2018 - 08/2003
8	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2002
8	CalciumIBA 01/2022 - 03/2005
8	Matrix Metalloproteinases (MMPs)IBA 10/2019 - 06/2015
7	LipopolysaccharidesIBA 06/2022 - 06/2014
7	Long Noncoding RNAIBA 01/2022 - 03/2016
7	Peptides (Polypeptides)IBA 08/2021 - 07/2010
7	Indicators and Reagents (Reagents)IBA 05/2021 - 06/2014
6	LigandsIBA 06/2022 - 06/2013
6	AntibodiesIBA 06/2022 - 05/2013
6	InflammasomesIBA 06/2022 - 01/2018
6	CholesterolIBA 03/2022 - 12/2008
6	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022 - 08/2014
6	ErbB Receptors (EGF Receptor)IBA 03/2022 - 05/2014
6	Arginine (L-Arginine)FDA Link 01/2022 - 01/2004

Therapy/Procedure

82	Therapeutics 10/2022 - 03/2005
32	Drug Therapy (Chemotherapy) 04/2022 - 07/2007
28	Immunotherapy 06/2022 - 01/2004
11	Resuscitation 07/2019 - 09/2004
11	Cardiopulmonary Resuscitation (CPR) 10/2017 - 06/2004
10	Transplantation 01/2021 - 03/2005
9	Artificial Respiration (Mechanical Ventilation) 01/2021 - 09/2004
8	Stents 05/2022 - 01/2015
8	Aftercare (After-Treatment) 11/2021 - 10/2014
8	Ligation 06/2020 - 02/2006
7	Neoadjuvant Therapy 01/2022 - 01/2014
7	Gastrectomy 10/2020 - 01/2013